The aim of this work was to ask more use of clinical pharmacists in medical team .The application of pharmaceutical care principle in practice settings can improve clinical outcomes, reducing therapy errors and containment cost. An opportunity to use pharmacist's expertise in assisting physician's drug and medical devices specialists. Isn't time for the medical community to get aid of the clinical pharmacists to work side by side and assist the physicians, in order to give a better care, protect and safeguard patients. The rationale of this focus article was to invite pharmacists to take a much more active role and to help physicians using their expertise in order to complete the therapeutic work in a more rational way. Pharmacists need to get out of their private stores, sharing their expertise and knowledge, by making active presence in the very infrastructure of clinical centers, such as hospitals and ambulatory.Physicians alone cannot cover every aspect of the pharmacological treatment, for example in the field of drug therapy monitoring, interactions, adverse drug reaction (ADR), toxicology, novel delivery systems, immunoglobuline-based therapeutics and other innovative drugs and medical devices systems, which have their pharmaceutical specific worlds.
Introduction
The pharmacist role needs to be actually changed, and this change can be used also to improve patient's clinical outcomes. Helper and strand in "Opportunities and responsibilities in Pharmaceutical Care" in 1990 wrote, "changing the focus of practice from products and biological systems to ensuring the best drug therapy and patient safety will raise the pharmacy's level of responsibility and require philosophical, organizational, and functional changes" Other factors to take into the count are that patients normally comply more easily and are more comfortable with the pharmacist, for a number of reasons, for instance, the patient can visit the community pharmacist without restraint, appointment and above all free of charge, where, the visit to a physician normally has financial costs and consumes a lot of time.
This accessibility to the patient gives a great chance to the pharmaceutical clinician in assisting the both physician and patient and sometimes in communicating between them. For instance, often the patient doesn't know that the antihistaminic prescribed by the physician was not a etiological cure but symptomatic drugs.
Also the clinical pharmacist with a deep knowledge in clinical cases and in the diagnostic matter is a great resource in both private and hospital medical team and it's obvious it will prevent many unfortunate and preventable failures; therefore, therefore it will definitely end up in a better patients' clinical outcome and a better quality of their lives.
Otherwise, this approach gives some economic benefits because we can observe errors and hospitalization days' decrease, a better drugs' use and as a consequence also a reduction of stocks of drugs and medical device. 
Materials and Methods
To examine deeper this argument, we analyzed some scientific articles published around the word in different pharmacist's working 
Result
In these studies, we observe a general positive influence of pharmacist's presence in the medical team also in different clinical outcomes.
Discussions
The following factors are the major driving forces behind healthcare systems changes: imaging professionals has to be evolvedin more rational way.
All of these indicate that the current medical/healthcare systems are not only subject to change but also not necessarily the best and in some countries actually dysfunctional.
Therefore, although each country has to tailor its own system, but the role of the clinical professionals, as campaign activists in making changes in these systems, in a way to benefit the patient's both health and safety, in all countries is certainly a crucial necessity.
In certain countries the shortcoming of pharmacists to take side of the patients is unforgivable, therefore we have many reasons to believe that such publications are not only essential, but also there is a lack of presence of the pharmacists at the right level in the healthcare system, and therefore, there it's crucial need in making a change in the patients' safety management.
In Italy, for instance, there is a need to increase the level of responsibility in therapy field, as widespread as in other countries for example USA, UK.
In Italy, we don't have a regulatory requirement but only a ministerial recommendation about ward pharmacist's presence in hospital settings as for example in the oncology field.
Italian national experience has given as result the reduction of 35%
of drugs' and medical devices' costs and therapy errors. The number of hospitals and organizations using ward pharmacists is increasing to raise a better safety in the medication system even if standards' levels are not yet pointed out.
To deep apply pharmaceutical care principles represents a great opportunity in all countries in order to improve clinical and economic outcomes but we think also for ethical reason.
There are two strategies in applying ward pharmacist presence: So every clinical department cooperates the assigned pharmacist to monitor costs and other pharmaceutical needs.
Every pharmacist attends to a specific department or area (surgeryInternal medicine, emergency, medicine, diagnostic imaging, medicine laboratory) to rationalize prescription according to Ebm criteria, patientns clinical needs, local and national policy, budget assigned.
In our hospital our specialist's pharmacists have their own fields (medical devices, Toxicology, oncology, nutritional, infectious disease, medicinal gas quality control) and are involved in Pharmacological therapy and also in ward economic management.
As clinical activity our pharmacists manage oncologic pharmacy therapies to prepare standard and particular doses checking the right dosage and mix of drugs ensuring the right therapy and Monitoring costs.We have a specialized pharmacist full time involved in medical devices management that evaluates the ward request helping to balance costs and sureness and controlled legal claims or ministerial recalls of products.
From 2007 we also have adose unit system that supports pharmaceutical care activities.
Our galenical laboratory prepares magistral formulas for tree pediatric wards, including cardiologic surgery pediatrics.
The hospital is also a rare metabolic disease regional centre and we take care about children needs particular drugs and nutrition .
For adult patients we have a nutritional team dedicated with clinical pharmacist.
For all other wards in discharge from hospital activity the clinical pharmacists not only provide drugs and medical devices and nutrition but also monitor prescriptions and provide pharmaceutical care to patients.
Also advisory activity is provided in field of nuclear medicine (radiopharmaceuticals), diagnostic imaging (contrast agents) and laboratory medicine (reagent, diagnostic in vitro).
Clinical pharmacists are applied in ethical committee. It was about practical activity concerning a bibliography research in biomedical databases about this subject. It was also required a write comment on the effect of clinical pharmacists presence in the medical team.
Conclusions
This article wants to improve the pharmaceutical care application in countries with an advanced healthcare system in order to provide more rational drug therapy to patients. This is hard to realize without ward clinical pharmacist. We believe this is not limited to Italy; many other nations suffer from the same syndrome, rigidity in their bureaucratic systems, and in this case "health care bureaucratic system".
We don't claim USA has the best health care system, but we believe We believe there is a damage done on the public safety, because of such a bureaucratic rigidity and that pharmacist's activism in this field will safeguard the best interest of the patient's health.
We believe that our pharmacist's satisfaction to the current circumstances or silence is not noble, and there is a need to break this passive atmosphere where it is.
We believe this article is just to beginning for a global movement and if we don't do something about it, no UN or WHO officials would know or care at the right level.
A discussion must be opened, under the light of the results of clinical studies, and the bibliography published in this filed.
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